“Myriapod Complete Tumor Signature” Project

Diatech Pharmacogenetics is pleased to announce its participation in the cascade funding calls within the THE – TUSCANY HEALTH ECOSYSTEM, PRECISION MEDICINE & PERSONALIZED HEALTHCARE, with a project focused on developing a multigene signature (over 100 genes) for the detection of DNA and RNA in the oncology field.

Cascade funding call issued by Spoke 6 of the Tuscany Health Ecosystem, under the resources of the PNRR, M4C2 – Investment 1.5 – Creation and strengthening of “Innovation Ecosystems for Sustainability”, funded by the European Union – NextGenerationEU, aimed at Precision Medicine & Personalized Healthcare – University of Siena
CUP D43C22005430007

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter

You are leaving this research use-only area

You are about to access content intended for a different region. Information, regulatory status, and product availability may vary by location.

Do you wish to continue?

Select Your Region

Please select your region to access the content that is most relevant to your location and applicable regulations.